Acquisitions (Tables) - CareFusion [Member]

9 Months Ended

Jun. 30, 2015

Fair Value of Consideration Transferred

The fair value of consideration transferred was $12.538 billion and consisted of the components below.

(Millions of dollars)
Cash consideration	$	10,085
Noncash consideration-fair value of shares issued		2,269
Noncash consideration-fair value of stock options and other equity awards		184
Total consideration transferred	$	12,538

Fair Value of Company's Ordinary Shares Issued

The acquisition date fair value of the Company’s ordinary shares issued to CareFusion shareholders was calculated per the following (shares in millions):

(Millions of dollars, except per share data)
Total CareFusion shares outstanding		205.3
Conversion factor		0.0777
Number of the Company’s shares issued		15.9
Closing price of the Company’s stock on March 16, 2015	$	142.29
Fair value of the Company’s issued shares	$	2,269

Summary of Assets Acquired and Liabilities Assumed

All of the assets acquired and liabilities assumed in this acquisition have been allocated to the Company’s Medical segment.

(Millions of dollars)
Cash and equivalents	$	1,903
Trade receivables, net		486
Inventories		828
Net investment in sales-type leases		1,208
Property, plant and equipment		503
Customer relationships		3,360
Developed technology		2,510
Trademarks		380
Other intangible assets		185
Other assets		435
Total identifiable assets acquired		11,798
Long-term debt		(2,181	)
Deferred tax liabilities		(2,648	)
Other liabilities		(764	)
Total liabilities assumed		(5,592	)
Net identifiable assets acquired		6,205
Goodwill		6,333
Net assets acquired	$	12,538

Summary of Pro Forma Results

The following table provides the pro forma results for the three and nine-month periods ended June 30, 2015 and 2014 as if CareFusion had been acquired as of October 1, 2013.

	Three Months Ended June 30,				Nine Months Ended June 30,
(Millions of dollars, except per share data)	2015		2014		2015		2014
Revenues	$	3,133	$	3,279	$	9,301	$	9,256
Net Income	$	326	$	361	$	966	$	919
Diluted Earnings per Share	$	1.52	$	1.69	$	4.49	$	4.28